REQUEST A DEMO
Total
USD $0.00
Search more companies

Labeupharma S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmacies and Drug Stores | Management Consulting Services
Full name: Labeupharma S.A. Profile Updated: April 08, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Labeupharma S.A. is an enterprise in Ecuador, with the main office in Quito. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on July 19, 2018. It currently has a total number of 4 (2021) employees. The company’s latest financial report indicates a net sales revenue increase of 43.25% in 2022. Over the same period, its total assets grew by 38.07%.

Headquarters
Paul Rivet E30-54, Mokai Bldg.
Quito; Pichincha;

Contact Details: Purchase the Labeupharma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Labeupharma S.A. report to view the information.
Outstanding Shares:
Purchase the Labeupharma S.A. report to view the information.
Registered Capital:
Purchase the Labeupharma S.A. report to view the information.
Incorporation Date:
July 19, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
46.67%
Purchase this report to view the information.
26.67%
Purchase this report to view the information.
26.67%
Company Performance
Financial values in the chart are available after Labeupharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
43.25%
Total operating revenue
26.7%
Operating profit (EBIT)
177.81%
EBITDA
180.82%
Net Profit (Loss) for the Period
N/A
Total assets
38.07%
Total equity
-60.59%
Operating Profit Margin (ROS)
5.8%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
21.24%
Quick Ratio
0.15%
Cash Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?